AJO LP’s AngioDynamics ANGO Stock Holding History

AJO LP’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-160,908	Closed	-$2.78M	–	645
2018 Q1	$2.78M	Buy	+160,908	New	+$2.68M	0.01%	414

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

AJO LP's ANGO Position: Q2 2018 in Review

AJO LP sold out of AngioDynamics (ANGO) in Q2 2018, closing a stake of 160,908 shares — an estimated $2.78M sold.

AJO LP first reported a position in ANGO in Q1 2018 and held it in 1 quarter. The position peaked at $2.78M in Q1 2018. 174 funds tracked by Wall St. Rank hold ANGO as of Q2 2018.

AJO LP reported no remaining AngioDynamics position as of Q2 2018 after selling out during the quarter.
AJO LP sold 160,908 AngioDynamics shares in Q2 2018, an estimated $2.78M.
AJO LP first reported a position in AngioDynamics in Q1 2018 and held it in 1 quarter.
AJO LP's AngioDynamics position peaked at $2.78M in Q1 2018.
174 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2018.

Based on AJO LP's 13F filing for Q2 2018, filed 13 Aug 2018.